SynthesisBMC public health2025
Text messages as a tool to improve cardiovascular disease risk factors control: a systematic review and meta-analysis of randomized clinical trials.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Impact of health-promoting text messages on cardiovascular risk: findings from a randomized controlled trial in primary care.Frontiers in medicine · 2026Trial
- Engagement With Text Messaging Improves Cardiovascular Medication Adherence: Secondary Analysis of a Randomized Controlled Trial.Journal of medical Internet research · 2025Trial
- Observational
- Digital Educational Strategies to Implement Evidence-Based Care for Atherosclerotic Cardiovascular Disease.Current atherosclerosis reports · 2026Review
- Reshaping the cardiovascular continuum in the management of arterial and venous cardiovascular disease: a narrative review.Journal of comparative effectiveness research · 2026Review
- Development of a Health Text Message System to Support Stroke Prevention: A Component of the Love Your Brain Digital Platform.Health expectations : an international journal of public participation in health care and health policy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular diseases (CVDs) are the leading cause of global mortality, claiming 17.9 million lives annually. Major risk factors include unhealthy diets, physical inactivity, tobacco use, and excessive alcohol consumption. Text messaging interventions have the potential to improve individual risk factors and encourage healthy habits. These interventions have been shown to help manage risk factors and slow disease progression. This systematic review and meta-analysis aimed to evaluate the efficacy of text messaging interventions for the primary prevention of CVD risk factors.
methodsThis review followed the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines. Searches were conducted on PubMed, MEDLINE, Cochrane, Scopus, Web of Science, Embase, and CINAHL using MeSH and free-text terms related to cardiovascular disease and text messaging interventions on February 12, 2024.
resultsOut of 5,748 identified articles, 22 studies met the inclusion criteria. The meta-analysis revealed that text messaging interventions significantly improved medication adherence, with a pooled effect size (Mean Difference [MD]) of 0.62 (95% CI: 0.37 to 0.86; p < 0.01; I² = 0.0%). They also significantly reduced diastolic blood pressure (MD: -2.66; 95% CI: -4.63 to -0.70; I² = 85%; p < 0.01) and systolic blood pressure (MD: -6.12; 95% CI: -10.26 to -1.97; I² = 96%; p < 0.01). However, no significant improvements were observed in BMI, LDL, HDL, total cholesterol, or HbA1c levels.
conclusionText messaging interventions effectively improve medication adherence and reduce blood pressure, making them a promising tool for CVD risk control. However, their impact on other cardiovascular risk factors is limited, highlighting the need for further research to explore long-term effects and personalized interventions for diverse populations. Integrating these digital tools into healthcare strategies could enhance CVD prevention efforts and improve cardiovascular risk factor control outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.